インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • アカデミックキー
  • ジャーナル目次
  • ウルリッヒの定期刊行物ディレクトリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
このページをシェアする
ジャーナルチラシ
Flyer image

概要

Obesity and its Therapy: A Short Review

Leonardo Napples, Yun Ching, Stephen Carol Rette and Lovis D’Mello

Weight increase is an understood reaction of treatment with psychotropic medications. Over fifty years prior, medications, for example, amitriptyline (Elavil) and lithium were known not connected with significant increments in weight and notwithstanding new eras of psychotropic medications, this unwelcome symptom has held on. The amount of weight is picked up changes however when all is said in one state of mind stabilizers and antipsychotics medications cause more generous weight pick up than antidepressants. Two antipsychotics, clozapine (Clozaril) and olanzapine (Zyprexa) are connected with the best pervasiveness of weight addition; up to 31% of patients treated with clozapine and 40% with olanzapine build their weight amid treatment. Some temperament stabilizers, for example, valproate (Depakote) likewise are connected with an also high rate of weight addition. Mirtazapine (Remeron) and paroxetine (Paxil) are two antidepressants with the best weight increase potential among the antidepressants in spite of the fact that aside from buproprion (Wellbutrin) weight addition has been accounted for among the greater part of alternate medications in this classification.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません